Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 5/2008

01.11.2008

The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition

verfasst von: Prof. Dr. Hans-Jürgen Möller

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Sonderheft 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Europe has a rich tradition in psychopathology and psychiatric classification. This could be helpful developing new classification systems like ICD-11 and DSM-V. Some examples of this are described and further discussed, such as the categorical vs. the syndromatological approach, the relevance of hierarchical rules for the delineation of nosological entities, the antagonistic tradition of unitarian vs. splitting approaches and the relevance of a differentiated psychopathological description. Finally, the conclusion is that a too radical change of the classificatory system, e.g. in the direction of a purely symptomatical/dimensional systematic, or a totally new classification based on modern new biological findings, might be problematic and premature.
Literatur
1.
Zurück zum Zitat Abi-Dargham A (2004) Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol 7(Suppl 1):S1–S5PubMedCrossRef Abi-Dargham A (2004) Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol 7(Suppl 1):S1–S5PubMedCrossRef
2.
Zurück zum Zitat Akiskal H (2005) The bipolar spectrum: history, description, boundaries, and validity. In: Kasper S, Hirschfeld RMA (eds) Handbook of bipolar disorder. Taylor & Francis, Abingdon, Oxford, London pp 49–68 Akiskal H (2005) The bipolar spectrum: history, description, boundaries, and validity. In: Kasper S, Hirschfeld RMA (eds) Handbook of bipolar disorder. Taylor & Francis, Abingdon, Oxford, London pp 49–68
3.
Zurück zum Zitat Akiskal H (2007) The interface of affective and schizophrenic disorders: a cross between two spectra? In: Marneros A, Akiskal H (eds) The overlap of affective and schizophrenic spectra. Cambridge University Press, Cambridge, pp 277–291 Akiskal H (2007) The interface of affective and schizophrenic disorders: a cross between two spectra? In: Marneros A, Akiskal H (eds) The overlap of affective and schizophrenic spectra. Cambridge University Press, Cambridge, pp 277–291
4.
Zurück zum Zitat Akiskal HS (1999) Bipolar disorder: outcome. New Engl J Med 341:1861–1862CrossRef Akiskal HS (1999) Bipolar disorder: outcome. New Engl J Med 341:1861–1862CrossRef
5.
Zurück zum Zitat Akiskal HS (2002) The bipolar spectrum–the shaping of a new paradigm in psychiatry. Curr Psychiatry Rep 4:1–3PubMedCrossRef Akiskal HS (2002) The bipolar spectrum–the shaping of a new paradigm in psychiatry. Curr Psychiatry Rep 4:1–3PubMedCrossRef
6.
Zurück zum Zitat Angst J (2002) Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia. Schizophr Res 57:5–13PubMedCrossRef Angst J (2002) Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia. Schizophr Res 57:5–13PubMedCrossRef
7.
Zurück zum Zitat Angst J, Felder W, Lohmeier B (1979) A genetic study on schizoaffective disorders. In: Obiols J, Ballus C, Gonzales Monclus E (eds) Biological psychiatry today. Elsevier, North Holland Biomedical Press, Amsterdam, pp 12–18 Angst J, Felder W, Lohmeier B (1979) A genetic study on schizoaffective disorders. In: Obiols J, Ballus C, Gonzales Monclus E (eds) Biological psychiatry today. Elsevier, North Holland Biomedical Press, Amsterdam, pp 12–18
8.
Zurück zum Zitat Angst J, Perris C (1968) Zur Nosologie endogener Depressionen. Arch Psychiatr Nervenkr 219:373–386CrossRef Angst J, Perris C (1968) Zur Nosologie endogener Depressionen. Arch Psychiatr Nervenkr 219:373–386CrossRef
9.
Zurück zum Zitat Angst J, Scharfetter C (1979) Subtypes of schizophrenia and affective disorders from a genetic viewpoint. In: Obiols J, Ballus C, Gonzales Monclus E (eds) Biolgical psychiatry today. Elsevier, North Holland Biomedical Press, Amsterdam, pp 351–357 Angst J, Scharfetter C (1979) Subtypes of schizophrenia and affective disorders from a genetic viewpoint. In: Obiols J, Ballus C, Gonzales Monclus E (eds) Biolgical psychiatry today. Elsevier, North Holland Biomedical Press, Amsterdam, pp 351–357
10.
Zurück zum Zitat Angst J, Sellaro R, Stassen HH, Gamma A (2005) Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J Affect Disord 84:149–157PubMedCrossRef Angst J, Sellaro R, Stassen HH, Gamma A (2005) Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J Affect Disord 84:149–157PubMedCrossRef
11.
Zurück zum Zitat Apud JA, Weinberger DR (2007) Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors. CNS Drugs 21:535–557PubMedCrossRef Apud JA, Weinberger DR (2007) Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors. CNS Drugs 21:535–557PubMedCrossRef
12.
Zurück zum Zitat Bleuler E (1972) Lehrbuch der Psychiatrie, 12th edn. Springer, Berlin Bleuler E (1972) Lehrbuch der Psychiatrie, 12th edn. Springer, Berlin
13.
Zurück zum Zitat Bogerts B, Falkai P, Haupts M et al (1990) Post-mortem volume measurement of limbic system and basal ganglia structures in chronic schizophrenics. Schizophr Res 3:295–301PubMedCrossRef Bogerts B, Falkai P, Haupts M et al (1990) Post-mortem volume measurement of limbic system and basal ganglia structures in chronic schizophrenics. Schizophr Res 3:295–301PubMedCrossRef
14.
Zurück zum Zitat Bogerts B, Lieberman J (1993) Neuropathology in the study of psychiatric disease. In: Costa e Silva ACJ, Nadelson CC (eds) International review of psychiatry, 1st edn. American Psychiatric Press, Washington, DC Bogerts B, Lieberman J (1993) Neuropathology in the study of psychiatric disease. In: Costa e Silva ACJ, Nadelson CC (eds) International review of psychiatry, 1st edn. American Psychiatric Press, Washington, DC
15.
Zurück zum Zitat Bonhoeffer K (1912) Die Psychosen im Gefolge von akuten Infektionen, Allgemeinerkrankungen und inneren Erkrankungen. In: Aschaffenburg G (ed) Handbuch der Psychiatrie. Leiptig Vienna, Deutike, pp 1–118 Bonhoeffer K (1912) Die Psychosen im Gefolge von akuten Infektionen, Allgemeinerkrankungen und inneren Erkrankungen. In: Aschaffenburg G (ed) Handbuch der Psychiatrie. Leiptig Vienna, Deutike, pp 1–118
16.
Zurück zum Zitat Boteva K, Lieberman J (2003) Reconsidering the classification of schizophrenia and manic depressive illness–a critical analysis and new conceptual model. World J Biol Psychiatry 4:81–92PubMed Boteva K, Lieberman J (2003) Reconsidering the classification of schizophrenia and manic depressive illness–a critical analysis and new conceptual model. World J Biol Psychiatry 4:81–92PubMed
17.
Zurück zum Zitat Brockington J (1981) The nosological status of schizoaffective psychosis. In: Perris C, Struwe G, Jansson B (eds) Biological psychiatry. vol 5. Elsevier, North Holland Biomedical Press, Amsterdam, pp 482–485 Brockington J (1981) The nosological status of schizoaffective psychosis. In: Perris C, Struwe G, Jansson B (eds) Biological psychiatry. vol 5. Elsevier, North Holland Biomedical Press, Amsterdam, pp 482–485
18.
Zurück zum Zitat Cahn W, Hulshoff Pol HE, Bongers M, Schnack HG, Mandl RC, Van Haren NE, Durston S, Koning H, Van Der Linden JA, Kahn RS (2002) Brain morphology in antipsychotic-naive schizophrenia: a study of multiple brain structures. Br J Psychiatry Suppl 43:s66–s72 Cahn W, Hulshoff Pol HE, Bongers M, Schnack HG, Mandl RC, Van Haren NE, Durston S, Koning H, Van Der Linden JA, Kahn RS (2002) Brain morphology in antipsychotic-naive schizophrenia: a study of multiple brain structures. Br J Psychiatry Suppl 43:s66–s72
19.
Zurück zum Zitat Cahn W, Hulshoff Pol HE, Lems EB, Van Haren NE, Schnack HG, Van Der Linden JA, Schothorst PF, van Engeland H, Kahn RS (2002) Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry 59:1002–1010PubMedCrossRef Cahn W, Hulshoff Pol HE, Lems EB, Van Haren NE, Schnack HG, Van Der Linden JA, Schothorst PF, van Engeland H, Kahn RS (2002) Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry 59:1002–1010PubMedCrossRef
20.
Zurück zum Zitat Cahn W, Van Haren NE, Hulshoff Pol HE, Schnack HG, Caspers E, Laponder DA, Kahn RS (2006) Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. Br J Psychiatry 189:381–382PubMedCrossRef Cahn W, Van Haren NE, Hulshoff Pol HE, Schnack HG, Caspers E, Laponder DA, Kahn RS (2006) Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. Br J Psychiatry 189:381–382PubMedCrossRef
21.
Zurück zum Zitat Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P (2002) A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 159:539–545PubMedCrossRef Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P (2002) A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 159:539–545PubMedCrossRef
22.
Zurück zum Zitat Carlsson A (1978) Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry 135:165–173PubMed Carlsson A (1978) Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry 135:165–173PubMed
23.
Zurück zum Zitat Carpenter WT (2007) Deconstructing and reconstructing illness syndromes associated with psychosis. World Psychiatry 6:92–93PubMed Carpenter WT (2007) Deconstructing and reconstructing illness syndromes associated with psychosis. World Psychiatry 6:92–93PubMed
24.
Zurück zum Zitat Carpenter WT (2007) Schizophrenia: diagnostic class or domains of pathology. Schizophr Res 33:203 Carpenter WT (2007) Schizophrenia: diagnostic class or domains of pathology. Schizophr Res 33:203
25.
Zurück zum Zitat Cichon S, Schumacher J, Muller DJ, Hurter M, Windemuth C, Strauch K, Hemmer S, Schulze TG, Schmidt-Wolf G, Albus M et al (2001) A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet 10:2933–2944PubMedCrossRef Cichon S, Schumacher J, Muller DJ, Hurter M, Windemuth C, Strauch K, Hemmer S, Schulze TG, Schmidt-Wolf G, Albus M et al (2001) A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet 10:2933–2944PubMedCrossRef
26.
Zurück zum Zitat Conus P, Abdel-Baki A, Harrigan S, Lambert M, McGorry PD (2004) Schneiderian first rank symptoms predict poor outcome within first episode manic psychosis. J Affect Disord 81:259–268PubMedCrossRef Conus P, Abdel-Baki A, Harrigan S, Lambert M, McGorry PD (2004) Schneiderian first rank symptoms predict poor outcome within first episode manic psychosis. J Affect Disord 81:259–268PubMedCrossRef
27.
Zurück zum Zitat Corfas G, Roy K, Buxbaum JD (2004) Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 7:575–580PubMedCrossRef Corfas G, Roy K, Buxbaum JD (2004) Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 7:575–580PubMedCrossRef
28.
Zurück zum Zitat Coryell W, Leon AC, Turvey C, Akiskal HS, Mueller T, Endicott J (2001) The significance of psychotic features in manic episodes: a report from the NIMH collaborative study. J Affect Disord 67:79–88PubMedCrossRef Coryell W, Leon AC, Turvey C, Akiskal HS, Mueller T, Endicott J (2001) The significance of psychotic features in manic episodes: a report from the NIMH collaborative study. J Affect Disord 67:79–88PubMedCrossRef
29.
Zurück zum Zitat Craddock N, O’Donovan MC, Owen MJ (2006) Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 32:9–16PubMedCrossRef Craddock N, O’Donovan MC, Owen MJ (2006) Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 32:9–16PubMedCrossRef
30.
Zurück zum Zitat Craddock N, Owen MJ (2005) The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 186:364–366PubMedCrossRef Craddock N, Owen MJ (2005) The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 186:364–366PubMedCrossRef
31.
Zurück zum Zitat Crow TJ (1987) Psychosis as a continuum and the virogene concept. Br Med Bull 43:754–767PubMed Crow TJ (1987) Psychosis as a continuum and the virogene concept. Br Med Bull 43:754–767PubMed
32.
Zurück zum Zitat Crow TJ (1990) Nature of the genetic contribution to psychotic illness–a continuum viewpoint. Acta Psychiatr Scand 81:401–408PubMedCrossRef Crow TJ (1990) Nature of the genetic contribution to psychotic illness–a continuum viewpoint. Acta Psychiatr Scand 81:401–408PubMedCrossRef
33.
Zurück zum Zitat Crow TJ (1990) The continuum of psychosis and its genetic origins. The sixty-fifth Maudsley lecture. Br J Psychiatry 156:788–797PubMedCrossRef Crow TJ (1990) The continuum of psychosis and its genetic origins. The sixty-fifth Maudsley lecture. Br J Psychiatry 156:788–797PubMedCrossRef
34.
Zurück zum Zitat Crow TJ (1995) A continuum of psychosis, one human gene, and not much else–the case for homogeneity. Schizophr Res 17:135–145PubMedCrossRef Crow TJ (1995) A continuum of psychosis, one human gene, and not much else–the case for homogeneity. Schizophr Res 17:135–145PubMedCrossRef
35.
Zurück zum Zitat Crow TJ (2007) How and why genetic linkage has not solved the problem of psychosis: review and hypothesis. Am J Psychiatry 164:13–21PubMedCrossRef Crow TJ (2007) How and why genetic linkage has not solved the problem of psychosis: review and hypothesis. Am J Psychiatry 164:13–21PubMedCrossRef
36.
Zurück zum Zitat Dixon L (1999) Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res 35 Suppl:S93–S100PubMedCrossRef Dixon L (1999) Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res 35 Suppl:S93–S100PubMedCrossRef
37.
Zurück zum Zitat Dixon L, Green-Paden L, Delahanty J, Lucksted A, Postrado L, Hall J (2001) Variables associated with disparities in treatment of patients with schizophrenia and comorbid mood and anxiety disorders. Psychiatr Serv 52:1216–1222PubMedCrossRef Dixon L, Green-Paden L, Delahanty J, Lucksted A, Postrado L, Hall J (2001) Variables associated with disparities in treatment of patients with schizophrenia and comorbid mood and anxiety disorders. Psychiatr Serv 52:1216–1222PubMedCrossRef
38.
Zurück zum Zitat Dunayevich E, Keck PE Jr (2000) Prevalence and description of psychotic features in bipolar mania. Curr Psychiatry Rep 2:286–290PubMedCrossRef Dunayevich E, Keck PE Jr (2000) Prevalence and description of psychotic features in bipolar mania. Curr Psychiatry Rep 2:286–290PubMedCrossRef
39.
Zurück zum Zitat Falret JP (1851) Marche de la folie. Gaz Hop 24:18–19 Falret JP (1851) Marche de la folie. Gaz Hop 24:18–19
40.
Zurück zum Zitat Fish F (1963) The unitary psychosis—a neurophysiological model. Confin Psychiatr 23:155–170 Fish F (1963) The unitary psychosis—a neurophysiological model. Confin Psychiatr 23:155–170
41.
Zurück zum Zitat Flor-Henry P, Lind JC, Koles ZJ (2004) A source-imaging (low-resolution electromagnetic tomography) study of the EEGs from unmedicated males with depression. Psychiatry Res 130:191–207PubMedCrossRef Flor-Henry P, Lind JC, Koles ZJ (2004) A source-imaging (low-resolution electromagnetic tomography) study of the EEGs from unmedicated males with depression. Psychiatry Res 130:191–207PubMedCrossRef
42.
Zurück zum Zitat Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G, Bottlender R, Schüle C, Zwanzger P, Engel RR et al (2004) Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry 61:177–183PubMedCrossRef Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G, Bottlender R, Schüle C, Zwanzger P, Engel RR et al (2004) Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry 61:177–183PubMedCrossRef
43.
Zurück zum Zitat Frodl T, Schaub A, Banac S, Charypar M, Jager M, Kummler P, Bottlender R, Zetzsche T, Born C, Leinsinger G et al (2006) Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J Psychiatry Neurosci 31:316–323PubMed Frodl T, Schaub A, Banac S, Charypar M, Jager M, Kummler P, Bottlender R, Zetzsche T, Born C, Leinsinger G et al (2006) Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J Psychiatry Neurosci 31:316–323PubMed
44.
Zurück zum Zitat Goldschmith RJ (1999) Overview of psychiatric comorbidity. Practical and theoretic considerations. Psychiatr Clin North Am 22:331–349CrossRef Goldschmith RJ (1999) Overview of psychiatric comorbidity. Practical and theoretic considerations. Psychiatr Clin North Am 22:331–349CrossRef
45.
Zurück zum Zitat Gray JA, Roth BL (2007) Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr Bull 33:1100–1119PubMedCrossRef Gray JA, Roth BL (2007) Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr Bull 33:1100–1119PubMedCrossRef
46.
Zurück zum Zitat Griesinger W (1845) Die Pathologie und Therapie der psychischen Krankheiten. Krabbe, Stuttgart Griesinger W (1845) Die Pathologie und Therapie der psychischen Krankheiten. Krabbe, Stuttgart
47.
Zurück zum Zitat Grossman LS, Harrow M, Goldberg JF, Fichtner CG (1991) Outcome of schizoaffective disorder at two long-term follow-ups: comparisons with outcome of schizophrenia and affective disorders. Am J Psychiatry 148:1359–1365PubMed Grossman LS, Harrow M, Goldberg JF, Fichtner CG (1991) Outcome of schizoaffective disorder at two long-term follow-ups: comparisons with outcome of schizophrenia and affective disorders. Am J Psychiatry 148:1359–1365PubMed
48.
Zurück zum Zitat Guillin O, Abi-Dargham A, Laruelle M (2007) Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 78:1–39PubMedCrossRef Guillin O, Abi-Dargham A, Laruelle M (2007) Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 78:1–39PubMedCrossRef
49.
Zurück zum Zitat Guislain J (1833) Traite des phrenopathies ou doctrine nouvelle des maladies mentales. Etablissement Enceclopedique, Brüssel Guislain J (1833) Traite des phrenopathies ou doctrine nouvelle des maladies mentales. Etablissement Enceclopedique, Brüssel
50.
Zurück zum Zitat Häfner H, Maurer K, Trendler G, an der Heiden W, Schmidt M (2005) The early course of schizophrenia and depression. Eur Arch Psychiatry Clin Neurosci 255:167–173 Häfner H, Maurer K, Trendler G, an der Heiden W, Schmidt M (2005) The early course of schizophrenia and depression. Eur Arch Psychiatry Clin Neurosci 255:167–173
51.
Zurück zum Zitat Harrow M, Grossman LS, Herbener ES, Davies EW (2000) Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. Br J Psychiatry 177:421–426PubMedCrossRef Harrow M, Grossman LS, Herbener ES, Davies EW (2000) Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. Br J Psychiatry 177:421–426PubMedCrossRef
52.
Zurück zum Zitat Hegerl U, Juckel G, Muller-Schubert A, Pietzcker A, Gaebel W (1995) Schizophrenics with small P300: a subgroup with a neurodevelopmental disturbance and a high risk for tardive dyskinesia? Acta Psychiatr Scand 91:120–125PubMedCrossRef Hegerl U, Juckel G, Muller-Schubert A, Pietzcker A, Gaebel W (1995) Schizophrenics with small P300: a subgroup with a neurodevelopmental disturbance and a high risk for tardive dyskinesia? Acta Psychiatr Scand 91:120–125PubMedCrossRef
53.
Zurück zum Zitat Hoche P (1912) Die Bedeutung der Symptomkomplexe in der Psychiatrie. Z Gesamte Neurol Psychiatr 12:540–551CrossRef Hoche P (1912) Die Bedeutung der Symptomkomplexe in der Psychiatrie. Z Gesamte Neurol Psychiatr 12:540–551CrossRef
54.
Zurück zum Zitat Höschl C (2007) Psychiatric diagnosis and classification from the European perspective. Die Psychiatrie 4:113–115 Höschl C (2007) Psychiatric diagnosis and classification from the European perspective. Die Psychiatrie 4:113–115
55.
Zurück zum Zitat Hurlemann R, Matusch A, Kuhn KU, Berning J, Elmenhorst D, Winz O, Kolsch H, Zilles K, Wagner M, Maier W et al (2007) 5-HT(2A) receptor density is decreased in the at-risk mental state. Psychopharmacology (Berl) 195(4):579–590 Hurlemann R, Matusch A, Kuhn KU, Berning J, Elmenhorst D, Winz O, Kolsch H, Zilles K, Wagner M, Maier W et al (2007) 5-HT(2A) receptor density is decreased in the at-risk mental state. Psychopharmacology (Berl) 195(4):579–590
56.
57.
Zurück zum Zitat Jaspers K (1965) Allgemeine psychopathologie, 8th edn. Springer, Berlin Jaspers K (1965) Allgemeine psychopathologie, 8th edn. Springer, Berlin
58.
Zurück zum Zitat Kahlbaum K (1863) Die Gruppierung der psychischen Krankheiten und die Einteilung der Seelenstörungen. AW Kafemann, Danzig Kahlbaum K (1863) Die Gruppierung der psychischen Krankheiten und die Einteilung der Seelenstörungen. AW Kafemann, Danzig
59.
Zurück zum Zitat Kasanin J (1994) The acute schizoaffective psychoses. 1933. Am J Psychiatry 151:144–154PubMed Kasanin J (1994) The acute schizoaffective psychoses. 1933. Am J Psychiatry 151:144–154PubMed
60.
Zurück zum Zitat Keck PE Jr, McElroy SL, Havens JR, Altshuler LL, Nolen WA, Frye MA, Suppes T, Denicoff KD, Kupka R, Leverich GS et al (2003) Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. Compr Psychiatry 44:263–269PubMedCrossRef Keck PE Jr, McElroy SL, Havens JR, Altshuler LL, Nolen WA, Frye MA, Suppes T, Denicoff KD, Kupka R, Leverich GS et al (2003) Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. Compr Psychiatry 44:263–269PubMedCrossRef
61.
Zurück zum Zitat Kehrer F, Kretschmer E (1924) Die Veranlagung zu seelischen Störungen (Monographien aus dem Gesamtgebiete der neurologie 40). Springer, Berlin Kehrer F, Kretschmer E (1924) Die Veranlagung zu seelischen Störungen (Monographien aus dem Gesamtgebiete der neurologie 40). Springer, Berlin
62.
Zurück zum Zitat Kendell RE (1978) The role of diagnosis in psychiatry. Blackwell, Oxford Kendell RE (1978) The role of diagnosis in psychiatry. Blackwell, Oxford
63.
Zurück zum Zitat Kendell RE (1988) Long-term followup studies: a commentary. Schizophr Bull 14:663–667PubMed Kendell RE (1988) Long-term followup studies: a commentary. Schizophr Bull 14:663–667PubMed
64.
Zurück zum Zitat Kleist K (1953) Die Gliederung der neuropsychischen Erkrankungen. Monatsschr Psychiatr Neurol 125:526–554PubMedCrossRef Kleist K (1953) Die Gliederung der neuropsychischen Erkrankungen. Monatsschr Psychiatr Neurol 125:526–554PubMedCrossRef
65.
Zurück zum Zitat Kraepelin E (1899) Psychiatrie. Ein Lehrbuch für Studierende und Ärzte, 6th edn. Johann Ambrosius Barth, Leipzig Kraepelin E (1899) Psychiatrie. Ein Lehrbuch für Studierende und Ärzte, 6th edn. Johann Ambrosius Barth, Leipzig
66.
Zurück zum Zitat Kraepelin E (1910) Psychiatire, 8th edn. (1st ed. 1883). Barth, Leipzig Kraepelin E (1910) Psychiatire, 8th edn. (1st ed. 1883). Barth, Leipzig
67.
Zurück zum Zitat Kraepelin E (1919) Dementia praecox. E. S. Liningstone, Edinburgh Kraepelin E (1919) Dementia praecox. E. S. Liningstone, Edinburgh
68.
Zurück zum Zitat Kreczmanski P, Heinsen H, Mantua V, Woltersdorf F, Masson T, Ulfig N, Schmidt-Kastner R, Korr H, Steinbusch HW, Hof PR et al (2007) Volume, neuron density and total neuron number in five subcortical regions in schizophrenia. Brain 130:678–692PubMedCrossRef Kreczmanski P, Heinsen H, Mantua V, Woltersdorf F, Masson T, Ulfig N, Schmidt-Kastner R, Korr H, Steinbusch HW, Hof PR et al (2007) Volume, neuron density and total neuron number in five subcortical regions in schizophrenia. Brain 130:678–692PubMedCrossRef
69.
Zurück zum Zitat Läge D, Möller HJ, Riedel M (2008) Exploring the structure of psychopathological symptoms—reconsidering the AMDP factor-analytic syndromes by combining the categorical and dimensional perspective. Int J Methods Psychiatr Res (in press) Läge D, Möller HJ, Riedel M (2008) Exploring the structure of psychopathological symptoms—reconsidering the AMDP factor-analytic syndromes by combining the categorical and dimensional perspective. Int J Methods Psychiatr Res (in press)
70.
Zurück zum Zitat Lapierre YD (1994) Schizophrenia and manic-depression: separate illnesses or a continuum? Can J Psychiatry 39:S59–S64PubMed Lapierre YD (1994) Schizophrenia and manic-depression: separate illnesses or a continuum? Can J Psychiatry 39:S59–S64PubMed
71.
Zurück zum Zitat Laviolette SR (2007) Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia? Schizophr Bull 33:971–981PubMedCrossRef Laviolette SR (2007) Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia? Schizophr Bull 33:971–981PubMedCrossRef
72.
Zurück zum Zitat Leonhard K (1968) Aufteilung der endogenen Psychosen, 4th edn. Akademie Verlag, Berlin Leonhard K (1968) Aufteilung der endogenen Psychosen, 4th edn. Akademie Verlag, Berlin
73.
Zurück zum Zitat Lieberman J, Chakos M, Wu H, Alvir J, Hoffman E, Robinson D, Bilder R (2001) Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry 49:487–499PubMedCrossRef Lieberman J, Chakos M, Wu H, Alvir J, Hoffman E, Robinson D, Bilder R (2001) Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry 49:487–499PubMedCrossRef
74.
Zurück zum Zitat Lieberman JA (2006) Neurobiology and the natural history of schizophrenia. J Clin Psychiatry 67(10):e14 Lieberman JA (2006) Neurobiology and the natural history of schizophrenia. J Clin Psychiatry 67(10):e14
75.
Zurück zum Zitat Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J et al (2005) Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 62:361–370PubMedCrossRef Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J et al (2005) Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 62:361–370PubMedCrossRef
76.
Zurück zum Zitat Maier W (2007) Common risk genes for affective and schizophrenic psychoses. Eur Arch Psychiatry Clin Neurosci 258(Suppl 2):37–40 Maier W (2007) Common risk genes for affective and schizophrenic psychoses. Eur Arch Psychiatry Clin Neurosci 258(Suppl 2):37–40
77.
Zurück zum Zitat Maier W, Zobel A, Rietschel M (2003) Genetics of schizophrenia and affective disorders. Pharmacopsychiatry 36(Suppl 3):S195–S202PubMed Maier W, Zobel A, Rietschel M (2003) Genetics of schizophrenia and affective disorders. Pharmacopsychiatry 36(Suppl 3):S195–S202PubMed
78.
Zurück zum Zitat Maj M (2007) Towards ICD-11 and DSM-V: some current problems of diagnosis in psychiatry. Eur Psychiatry 22:S1 Maj M (2007) Towards ICD-11 and DSM-V: some current problems of diagnosis in psychiatry. Eur Psychiatry 22:S1
79.
Zurück zum Zitat Marneros A (2000) Behandlung schizoaffektiver Psychosen. In: Möller HJ (ed) Therapie psychiatrischer Erkrankungen. Thieme, Stuttgart, pp 484–488 Marneros A (2000) Behandlung schizoaffektiver Psychosen. In: Möller HJ (ed) Therapie psychiatrischer Erkrankungen. Thieme, Stuttgart, pp 484–488
80.
Zurück zum Zitat Marneros A (2003) Schizoaffective disorder: clinical aspects, differential diagnosis, and treatment. Curr Psychiatry Rep 5(3):202–205PubMedCrossRef Marneros A (2003) Schizoaffective disorder: clinical aspects, differential diagnosis, and treatment. Curr Psychiatry Rep 5(3):202–205PubMedCrossRef
81.
Zurück zum Zitat Marneros A (2003) The schizoaffective phenomenon: the state of the art. Acta Psychiatr Scand Suppl:29–33 Marneros A (2003) The schizoaffective phenomenon: the state of the art. Acta Psychiatr Scand Suppl:29–33
82.
Zurück zum Zitat Marneros A (2007) The paradigma of overlapping affective and schizophrenic spectra: schizoaffective conditions. In: Marneros A, Akiskal H (eds) The overlap of affective and schizophrenic spectra. Cambridge University Press, Cambridge, pp 1–24 Marneros A (2007) The paradigma of overlapping affective and schizophrenic spectra: schizoaffective conditions. In: Marneros A, Akiskal H (eds) The overlap of affective and schizophrenic spectra. Cambridge University Press, Cambridge, pp 1–24
83.
Zurück zum Zitat Marneros A, Akiskal H (2007) The overlap of affective and schizophrenic spectra. Cambridge University Press, Cambridge Marneros A, Akiskal H (2007) The overlap of affective and schizophrenic spectra. Cambridge University Press, Cambridge
84.
Zurück zum Zitat Marneros A, Angst J (2000) Bipolar disorders. 100 years after manic-depressive insanity. Kluwer Academic Publishers, Dordrecht Marneros A, Angst J (2000) Bipolar disorders. 100 years after manic-depressive insanity. Kluwer Academic Publishers, Dordrecht
85.
Zurück zum Zitat Marneros A, Deister A, Rohde A (1986) The cologne study on schizoaffective disorders and schizophrenia suspecta. In: Marneros A, Tsuang MT (eds) Schizoaffective psychoses. Springer, Berlin, pp 123–142 Marneros A, Deister A, Rohde A (1986) The cologne study on schizoaffective disorders and schizophrenia suspecta. In: Marneros A, Tsuang MT (eds) Schizoaffective psychoses. Springer, Berlin, pp 123–142
86.
Zurück zum Zitat Marneros A, Deister A, Rohde A (1988) Syndrome shift in the long-term course of schizoaffective disorders. Eur Arch Psychiatry Neurol Sci 238:97–104PubMed Marneros A, Deister A, Rohde A (1988) Syndrome shift in the long-term course of schizoaffective disorders. Eur Arch Psychiatry Neurol Sci 238:97–104PubMed
87.
Zurück zum Zitat Marneros A, Deister A, Rohde A (1991) Affektive, schizoaffektive und schizophrene Psychosen. Eine vergleichende langzeitstudie. Springer, Berlin Marneros A, Deister A, Rohde A (1991) Affektive, schizoaffektive und schizophrene Psychosen. Eine vergleichende langzeitstudie. Springer, Berlin
88.
Zurück zum Zitat Marneros A, Deister A, Rohde A, Junemann H, Fimmers R (1988) Long-term course of schizoaffective disorders. Part I: definitions, methods, frequency of episodes and cycles. Eur Arch Psychiatry Neurol Sci 237:264–275PubMedCrossRef Marneros A, Deister A, Rohde A, Junemann H, Fimmers R (1988) Long-term course of schizoaffective disorders. Part I: definitions, methods, frequency of episodes and cycles. Eur Arch Psychiatry Neurol Sci 237:264–275PubMedCrossRef
89.
Zurück zum Zitat Marneros A, Röttig S, Röttig D, Tscharntke A, Brieger P (2007) Bipolar I disorder with mood-incongruent psychostic symptoms: a comparative longitudinal study. Eur Arch Psychiatry Clin Neurosci (in press) Marneros A, Röttig S, Röttig D, Tscharntke A, Brieger P (2007) Bipolar I disorder with mood-incongruent psychostic symptoms: a comparative longitudinal study. Eur Arch Psychiatry Clin Neurosci (in press)
90.
Zurück zum Zitat Martin RL, Cloninger CR, Guze SB, Clayton PJ (1985) Frequency and differential diagnosis of depressive syndromes in schizophrenia. J Clin Psychiatry 46:9–13PubMed Martin RL, Cloninger CR, Guze SB, Clayton PJ (1985) Frequency and differential diagnosis of depressive syndromes in schizophrenia. J Clin Psychiatry 46:9–13PubMed
91.
Zurück zum Zitat McGlashan TH (1988) A selective review of recent North Americoan long-term studies of schizophrenia. Schizophr Bull 14:11–14 McGlashan TH (1988) A selective review of recent North Americoan long-term studies of schizophrenia. Schizophr Bull 14:11–14
92.
Zurück zum Zitat Meisenzahl EM, Seifert D, Jäger M, Bottlender R, Schmitt G, Zetzsche T, Koutouleris N, Burgermeister B, Teipel S, Born C et al (2007) Hippocampal volume reductions in major depression and schizophrenia: a comparative structural MRI study. Submitted Meisenzahl EM, Seifert D, Jäger M, Bottlender R, Schmitt G, Zetzsche T, Koutouleris N, Burgermeister B, Teipel S, Born C et al (2007) Hippocampal volume reductions in major depression and schizophrenia: a comparative structural MRI study. Submitted
93.
Zurück zum Zitat Moller HJ (2005) Problems associated with the classification and diagnosis of psychiatric disorders. World J Biol Psychiatry 6:45–56PubMedCrossRef Moller HJ (2005) Problems associated with the classification and diagnosis of psychiatric disorders. World J Biol Psychiatry 6:45–56PubMedCrossRef
94.
Zurück zum Zitat Möller HJ (2008) Is there a need for a new psychiatric classification at the current state of knowledge? World J Biol Psychiatry Möller HJ (2008) Is there a need for a new psychiatric classification at the current state of knowledge? World J Biol Psychiatry
95.
Zurück zum Zitat Möller HJ (2008) Standardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales. World J Biol Psychiatry (in press) Möller HJ (2008) Standardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales. World J Biol Psychiatry (in press)
96.
Zurück zum Zitat Möller HJ (2008) The assessment of cognitive impairment would be a relevant addition to the criteria for diagnosing schizophrenia. World Psychiatry 7:35–36PubMed Möller HJ (2008) The assessment of cognitive impairment would be a relevant addition to the criteria for diagnosing schizophrenia. World Psychiatry 7:35–36PubMed
97.
Zurück zum Zitat Möller HJ (2008) The complexity of development trends and decision making in pharmacopsychiatry Möller HJ (2008) The complexity of development trends and decision making in pharmacopsychiatry
98.
Zurück zum Zitat Möller HJ, Bottlender R, Groß A, Hoff P, Wittmann J, Wegner U, Strauss A (2002) The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms. Schizophr Res 56:87–94PubMedCrossRef Möller HJ, Bottlender R, Groß A, Hoff P, Wittmann J, Wegner U, Strauss A (2002) The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms. Schizophr Res 56:87–94PubMedCrossRef
99.
Zurück zum Zitat Möller HJ, Bottlender R, Jäger M, Strauss A (2008) The Munich 15 years follow up study on first hospitalized patients with schizophrenia and affective psychosis: main outcome results (In press) Möller HJ, Bottlender R, Jäger M, Strauss A (2008) The Munich 15 years follow up study on first hospitalized patients with schizophrenia and affective psychosis: main outcome results (In press)
100.
Zurück zum Zitat Möller HJ, Schmid Bode W, Cording-Tömmel C, Wittchen HU, Zaudig M, von Zerssen D (1988) Psychopathological and social outcome in schizophrenia versus affective/schizoaffective psychoses and prediction of poor outcome in schizophrenia. Results from a 5–8 year follow-up. Acta Psychiatr Scand 77:379–389PubMedCrossRef Möller HJ, Schmid Bode W, Cording-Tömmel C, Wittchen HU, Zaudig M, von Zerssen D (1988) Psychopathological and social outcome in schizophrenia versus affective/schizoaffective psychoses and prediction of poor outcome in schizophrenia. Results from a 5–8 year follow-up. Acta Psychiatr Scand 77:379–389PubMedCrossRef
101.
Zurück zum Zitat Mulert C, Jager L, Pogarell O, Bussfeld P, Schmitt R, Juckel G, Hegerl U (2002) Simultaneous ERP and event-related fMRI: focus on the time course of brain activity in target detection. Methods Find Exp Clin Pharmacol 24 Suppl D:17–20PubMed Mulert C, Jager L, Pogarell O, Bussfeld P, Schmitt R, Juckel G, Hegerl U (2002) Simultaneous ERP and event-related fMRI: focus on the time course of brain activity in target detection. Methods Find Exp Clin Pharmacol 24 Suppl D:17–20PubMed
102.
Zurück zum Zitat Müller N, Schwarz MJ (2007) The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm Suppl:269–280 Müller N, Schwarz MJ (2007) The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm Suppl:269–280
103.
Zurück zum Zitat Murray RM, McDonald C, Bramon E (2002) Neurodevelopmental impairment, dopamine sensitisation, and social adversity in schizophrenia. World Psychiatry 1:137–145PubMed Murray RM, McDonald C, Bramon E (2002) Neurodevelopmental impairment, dopamine sensitisation, and social adversity in schizophrenia. World Psychiatry 1:137–145PubMed
104.
Zurück zum Zitat Murray RM, Sham P, van Os J, Zanelli J, Cannon M, McDonald C (2004) A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 71:405–416PubMedCrossRef Murray RM, Sham P, van Os J, Zanelli J, Cannon M, McDonald C (2004) A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 71:405–416PubMedCrossRef
105.
Zurück zum Zitat Neumeister A, Young T, Stastny J (2004) Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter. Psychopharmacology (Berl) 174:512–524CrossRef Neumeister A, Young T, Stastny J (2004) Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter. Psychopharmacology (Berl) 174:512–524CrossRef
106.
Zurück zum Zitat Pincus HA, Tew JD, First MB (2004) Psychiatric comorbidity: is more less? World Psychiatry 3:18–23PubMed Pincus HA, Tew JD, First MB (2004) Psychiatric comorbidity: is more less? World Psychiatry 3:18–23PubMed
107.
Zurück zum Zitat Rapoport JL, Addington AM, Frangou S, Psych MR (2005) The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 10:434–449PubMedCrossRef Rapoport JL, Addington AM, Frangou S, Psych MR (2005) The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 10:434–449PubMedCrossRef
108.
Zurück zum Zitat Rennert H (1977) Etiology and classification of mental disorders from viewpoint of “Universal genesis of psychoses”. Psychiatr Neurol Med Psychol (Leipz) 29:9–13 Rennert H (1977) Etiology and classification of mental disorders from viewpoint of “Universal genesis of psychoses”. Psychiatr Neurol Med Psychol (Leipz) 29:9–13
109.
Zurück zum Zitat Rujescu D, Bender A, Keck M, Hartmann AM, Ohl F, Raeder H, Giegling I, Genius J, McCarley RW, Moller HJ et al (2006) A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry 59:721–729PubMedCrossRef Rujescu D, Bender A, Keck M, Hartmann AM, Ohl F, Raeder H, Giegling I, Genius J, McCarley RW, Moller HJ et al (2006) A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry 59:721–729PubMedCrossRef
110.
Zurück zum Zitat Rujescu D, Hartmann AM, Gonnermann C, Moller HJ, Giegling I (2003) M129V variation in the prion protein may influence cognitive performance. Mol Psychiatry 8:937–941PubMedCrossRef Rujescu D, Hartmann AM, Gonnermann C, Moller HJ, Giegling I (2003) M129V variation in the prion protein may influence cognitive performance. Mol Psychiatry 8:937–941PubMedCrossRef
111.
Zurück zum Zitat Saugstad LF (1994) The maturational theory of brain development and cerebral excitability in the multifactorially inherited manic-depressive psychosis and schizophrenia. Int J Psychophysiol 18:189–203PubMedCrossRef Saugstad LF (1994) The maturational theory of brain development and cerebral excitability in the multifactorially inherited manic-depressive psychosis and schizophrenia. Int J Psychophysiol 18:189–203PubMedCrossRef
112.
Zurück zum Zitat Saugstad LF (1999) A lack of cerebral lateralization in schizophrenia is within the normal variation in brain maturation but indicates late, slow maturation. Schizophr Res %19;39: 183–196 Saugstad LF (1999) A lack of cerebral lateralization in schizophrenia is within the normal variation in brain maturation but indicates late, slow maturation. Schizophr Res %19;39: 183–196
113.
Zurück zum Zitat Saugstad LF (2001) Manic depressive psychosis and schizophrenia are neurological disorders at the extremes of CNS maturation and nutritional disorders associated with a deficit in marine fat. Med Hypotheses 57:679–692PubMedCrossRef Saugstad LF (2001) Manic depressive psychosis and schizophrenia are neurological disorders at the extremes of CNS maturation and nutritional disorders associated with a deficit in marine fat. Med Hypotheses 57:679–692PubMedCrossRef
114.
Zurück zum Zitat Saugstad LF (2007) What are psychosis and where is it located. Eur Arch Psychiatry Clin Neurosci (in press) Saugstad LF (2007) What are psychosis and where is it located. Eur Arch Psychiatry Clin Neurosci (in press)
115.
Zurück zum Zitat Schmitt GJ, Meisenzahl EM, Dresel S, Tatsch K, Rossmuller B, Frodl T, Preuss UW, Hahn K, Moller HJ (2002) Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine. J Psychopharmacol 16:200–206PubMedCrossRef Schmitt GJ, Meisenzahl EM, Dresel S, Tatsch K, Rossmuller B, Frodl T, Preuss UW, Hahn K, Moller HJ (2002) Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine. J Psychopharmacol 16:200–206PubMedCrossRef
116.
Zurück zum Zitat Schumacher J, Cichon S, Rietschel M, Nothen MM, Propping P (2002) Genetics of bipolar affective disorders. Current status of research for identification of susceptibility genes. Nervenarzt 73:581–592PubMedCrossRef Schumacher J, Cichon S, Rietschel M, Nothen MM, Propping P (2002) Genetics of bipolar affective disorders. Current status of research for identification of susceptibility genes. Nervenarzt 73:581–592PubMedCrossRef
117.
Zurück zum Zitat Strakowski SM, Williams JR, Sax KW, Fleck DE, DelBello MP, Bourne ML (2000) Is impaired outcome following a first manic episode due to mood-incongruent psychosis? J Affect Disord 61:87–94PubMedCrossRef Strakowski SM, Williams JR, Sax KW, Fleck DE, DelBello MP, Bourne ML (2000) Is impaired outcome following a first manic episode due to mood-incongruent psychosis? J Affect Disord 61:87–94PubMedCrossRef
118.
Zurück zum Zitat Subotnik KL, Nuechterlein KH, Asarnow RF, Fogelson DL, Goldstein MJ, Talovic SA (1997) Depressive symptoms in the early course of schizophrenia: relationship to familial psychiatric illness. Am J Psychiatry 154:1551–1556PubMed Subotnik KL, Nuechterlein KH, Asarnow RF, Fogelson DL, Goldstein MJ, Talovic SA (1997) Depressive symptoms in the early course of schizophrenia: relationship to familial psychiatric illness. Am J Psychiatry 154:1551–1556PubMed
119.
Zurück zum Zitat Tamminga CA (2006) The neurobiology of cognition in schizophrenia. J Clin Psychiatry 67(9):e11PubMedCrossRef Tamminga CA (2006) The neurobiology of cognition in schizophrenia. J Clin Psychiatry 67(9):e11PubMedCrossRef
120.
Zurück zum Zitat Tsuang MT, Dempsey GM (1979) Long-term outcome of major psychoses. II. Schizoaffective disorder compared with schizophrenia, affective disorders, and a surgical control group. Arch Gen Psychiatry 36:1302–1304PubMed Tsuang MT, Dempsey GM (1979) Long-term outcome of major psychoses. II. Schizoaffective disorder compared with schizophrenia, affective disorders, and a surgical control group. Arch Gen Psychiatry 36:1302–1304PubMed
121.
Zurück zum Zitat van Rd V (1993) Reactualization of the concept of unitary psychosis introduced by Joseph Guislain. Acta Psychiatr Belg 93:203–219 van Rd V (1993) Reactualization of the concept of unitary psychosis introduced by Joseph Guislain. Acta Psychiatr Belg 93:203–219
122.
Zurück zum Zitat Weinberger DR, Wagner RL, Wyatt RJ (1983) Neuropathological studies of schizophrenia: a selective review. Schizophr Bull 9:193–212PubMed Weinberger DR, Wagner RL, Wyatt RJ (1983) Neuropathological studies of schizophrenia: a selective review. Schizophr Bull 9:193–212PubMed
123.
Zurück zum Zitat Weis S, Llenos IC, Dulay JR, Elashoff M, Martinez-Murillo F, Miller CL (2007) Quality control for microarray analysis of human brain samples: the impact of postmortem factors, RNA characteristics, and histopathology. J Neurosci Methods 165:198–209PubMedCrossRef Weis S, Llenos IC, Dulay JR, Elashoff M, Martinez-Murillo F, Miller CL (2007) Quality control for microarray analysis of human brain samples: the impact of postmortem factors, RNA characteristics, and histopathology. J Neurosci Methods 165:198–209PubMedCrossRef
124.
Zurück zum Zitat Zeller E (1837) Bericht über die Wirksamkeit der heilanstalt Winnenthal von ihrer Eröffnung den 1. März 1834 bis zum 28. Februar 1837. Beil med Corresp Bl Wurtemb Ärztl Ver 7:321–335 Zeller E (1837) Bericht über die Wirksamkeit der heilanstalt Winnenthal von ihrer Eröffnung den 1. März 1834 bis zum 28. Februar 1837. Beil med Corresp Bl Wurtemb Ärztl Ver 7:321–335
Metadaten
Titel
The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition
verfasst von
Prof. Dr. Hans-Jürgen Möller
Publikationsdatum
01.11.2008
Verlag
D. Steinkopff-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe Sonderheft 5/2008
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-008-5004-4

Weitere Artikel der Sonderheft 5/2008

European Archives of Psychiatry and Clinical Neuroscience 5/2008 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.